BioHarvest Sciences

BHST · CANADIAN

$1.72+$0.04 (+2.38%)TodayMarket closed ·
Prev close $1.68

About BHST

BioHarvest Sciences, Inc. develops bio-cell growth platform technology. The firm leverages its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. The company is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two business verticals: as a contract development and production organization on behalf of customers seeking complex molecules, and as a creator of nutraceutical health and wellness products, which include dietary supplements. Its segments include Nutraceuticals and Pharmaceuticals. VINIA is a red grape cell-based supplement, which is a commercial nutraceutical product derived from the Botanical Synthesis platform and is clinically proven to improve blood flow, which enhances physical energy and mental alertness. VINIA contains multiple polyphenols, including Piceid Resveratrol, which is 25x more soluble in water than regular resveratrol.

Employees
89
Headquarters
Vancouver, British Columbia
Listed
Aug 5, 2015
Sector
Consumer Staples
Industry
Personal Care Products

Leadership

BioHarvest Sciences executives
NameTitleSince
Zaki Rakib—2018
Ilan Sobel——
Bar Dichter——
Ilana Belzer——
Yoheved Hagay——
David Ryan—2013
Michal Sapir——
Jared Turner——
Malkit Azachi——
Anne Binder——
John Fiddick——
Sharon Malka——
Vivien Rakib——
David Tsur——
Justin Meiklem—2025

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.